CMH :: Clinical and Molecular Hepatology

ORIGINAL ARTICLE Effect of antiviral therapy in reducing perinatal transmission of hepatitis B virus and maternal outcomes after discontinuing them
Background/Aims: There have been numerous efforts to reduce mother-to-child transmission (MTCT) of hepatitis B virus (HBV) with antiviral agents during pregnancy. However, there are limited data regarding the outcomes of pregnant women after delivery. This study was performed to...

ORIGINAL ARTICLE Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis
Background/Aims: Left ventricular diastolic dysfunction (LVDD) is an early manifestation of cardiac dysfunction in patients with liver cirrhosis (LC). However, the effect of LVDD on survival has not been clarified, especially in decompensated LC. Methods: We prospectively enrol...

CASE REPORT Bilateral optic neuropathy related to severe anemia in a patient with alcoholic cirrhosis: a case report and review of the literature
Anemia appears frequently in patients with alcoholic liver disease (ALD) but has never been linked to bilateral nonarteritic anterior ischemic optic neuropathy (NAION). A 65-year-old woman with a medical history of alcoholic cirrhosis was admitted for bilateral NAION. On admissi...

ORIGINAL ARTICLE The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study
Background/Aims: Leptin is associated with metabolic disorders, which predispose one to non-alcoholic fatty liver disease (NAFLD). The role of leptin in NAFLD pathogenesis is not fully understood. We aim to investigate the association between serum leptin level and severity of N...

Current Issue

Volume 24(4); Dec 2018

Volume 24(3); September 2018

Volume 24(2); June 2018

Volume 24(1); March 2018

Volume 23(4); December 2017

Most-cited are based on citations from 2017 ~ 2019.

Genetic predisposition in nonalcoholic fatty liver disease

Silvia Sookoian, Carlos J. Pirola

Clin Mol Hepatol.2017;23(1):1-12. Published online March 9, 2017
DOI: https://doi.org/10.3350/cmh.2016.0109

Cited By 36

Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis

Gaeun Kim, Moon Young Kim, Soon Koo Baik

Clin Mol Hepatol.2017;23(1):34-41. Published online March 7, 2017
DOI: https://doi.org/10.3350/cmh.2016.0059

Cited By 16

Radioembolization for the treatment of hepatocellular carcinoma

Hyo-Cheol Kim

Clin Mol Hepatol.2017;23(2):109-114. Published online May 10, 2017
DOI: https://doi.org/10.3350/cmh.2017.0004

Cited By 8

Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function

Hyun Phil Shin, Ji-Ae Park, Blaire Burman, Richard A. Kozarek, Asma Siddique

Clin Mol Hepatol.2017;23(4):316-322. Published online August 22, 2017
DOI: https://doi.org/10.3350/cmh.2016.0087

Cited By 8

Anticoagulation in cirrhosis: a new paradigm?

Filippo Leonardi, Nicola De Maria, Erica Villa

Clin Mol Hepatol.2017;23(1):13-21. Published online March 14, 2017
DOI: https://doi.org/10.3350/cmh.2016.0110

Cited By 7

Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study

Byeong Wook Cho, Seok Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae

Clin Mol Hepatol.2017;23(1):51-56. Published online March 16, 2017
DOI: https://doi.org/10.3350/cmh.2016.0053

Cited By 7

Epithelioid angiomyolipoma of the liver: a case report

Soo Yeon Lee, Baek-hui Kim

Clin Mol Hepatol.2017;23(1):91-94. Published online March 17, 2017
DOI: https://doi.org/10.3350/cmh.2017.0011

Cited By 7

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs

Stephen Caldwell

Clin Mol Hepatol.2017;23(2):103-108. Published online May 10, 2017
DOI: https://doi.org/10.3350/cmh.2017.0103

Cited By 7

Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system

Tae Kyoung Kim, Seung Yeon Noh, Stephanie R Wilson, Yuko Kono, Fabio Piscaglia, Hyun-Jung Jang, Andrej Lyshchik, Christoph F. Dietrich, Juergen K. Willmann, Alexander Vezeridis, Claude B Sirlin

Clin Mol Hepatol.2017;23(4):280-289. Published online September 15, 2017
DOI: https://doi.org/10.3350/cmh.2017.0037

Cited By 7

Current status and strategies for hepatitis B control in Korea

Eun Ju Cho, Sung Eun Kim, Ki Tae Suk, Jihyun An, Soung Won Jeong, Woo Jin Chung, Yoon Jun Kim

Clin Mol Hepatol.2017;23(3):205-211. Published online September 19, 2017
DOI: https://doi.org/10.3350/cmh.2017.0104

Cited By 7

Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma

Edward Wolfgang Lee, Sarah Khan

Clin Mol Hepatol.2017;23(4):265-272. Published online November 8, 2017
DOI: https://doi.org/10.3350/cmh.2017.0111

Cited By 7

Microbiota, a key player in alcoholic liver disease

Anne-Marie Cassard, Dragos Ciocan

Clin Mol Hepatol.2018;24(2):100-107. Published online December 22, 2017
DOI: https://doi.org/10.3350/cmh.2017.0067

Cited By 7

The use of immunosuppression in autoimmune hepatitis: A current literature review

Angela Cropley, Martin Weltman

Clin Mol Hepatol.2017;23(1):22-26. Published online March 14, 2017
DOI: https://doi.org/10.3350/cmh.2016.0089

Cited By 6

Aggressive tumor recurrence after radiofrequency ablation for hepatocellular carcinoma

Tae Wook Kang, Hyo Keun Lim, Dong Ik Cha

Clin Mol Hepatol.2017;23(1):95-101. Published online March 24, 2017
DOI: https://doi.org/10.3350/cmh.2017.0006

Cited By 6

A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function

Hyun Yang, Hyun Young Woo, Soon Kyu Lee, Ji Won Han, Bohyun Jang, Hee Chul Nam, Hae Lim Lee, Sung Won Lee, Do Seon Song, Myeong Jun Song, Jung Suk Oh, Ho Jong Chun, Jeong Won Jang, Angelo Lozada, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon

Clin Mol Hepatol.2017;23(2):128-137. Published online May 10, 2017
DOI: https://doi.org/10.3350/cmh.2016.0071

Cited By 6

Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B

Won Sohn, Ju-Yeon Cho, Ji Hoon Kim, Jung Il Lee, Hyung Joon Kim, Min-Ah Woo, Sin-Ho Jung, Yong-Han Paik

Clin Mol Hepatol.2017;23(2):170-178. Published online May 16, 2017
DOI: https://doi.org/10.3350/cmh.2016.0086

Cited By 5

Histopathological evaluation of liver fibrosis and cirrhosis regression

Regina C. Lo, Haeryoung Kim

Clin Mol Hepatol.2017;23(4):302-307. Published online December 20, 2017
DOI: https://doi.org/10.3350/cmh.2017.0078

Cited By 5

KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol.2018;24(3):230-277. Published online July 9, 2018
DOI: https://doi.org/10.3350/cmh.2018.1005

Cited By 5

Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir

Hee-Jeong Jeon, Seok Won Jung, Neung Hwa Park, Yujin Yang, Jin-Hee Noh, Jae-Sung Ahn, Hyung Rae Kim, Jae Ho Lee, Jung Woo Shin

Clin Mol Hepatol.2017;23(3):230-238. Published online June 30, 2017
DOI: https://doi.org/10.3350/cmh.2017.0003

Cited By 4

Current status of and strategies for hepatitis C control in South Korea

Beom Kyung Kim, Eun Sun Jang, Jeong Han Kim, Soo Young Park, Song Vogue Ahn, Hyung Joon Kim, Do Young Kim

Clin Mol Hepatol.2017;23(3):212-218. Published online September 19, 2017
DOI: https://doi.org/10.3350/cmh.2017.0105

Cited By 4

The Korean Association for the Study of the Liver